These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 8903631)
21. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension. Nadar SK; Al Yemeni E; Blann AD; Lip GY Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667 [TBL] [Abstract][Full Text] [Related]
22. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Blann AD; Dobrotova M; Kubisz P; McCollum CN Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997 [TBL] [Abstract][Full Text] [Related]
23. Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin. Verhaar MC; Beutler JJ; Gaillard CA; Koomans HA; Fijnheer R; Rabelink TJ J Hypertens; 1998 Jan; 16(1):45-50. PubMed ID: 9533416 [TBL] [Abstract][Full Text] [Related]
24. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852 [TBL] [Abstract][Full Text] [Related]
25. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124 [TBL] [Abstract][Full Text] [Related]
26. von Willebrand factor and endothelial damage in essential hypertension. Blann AD; Naqvi T; Waite M; McCollum CN J Hum Hypertens; 1993 Apr; 7(2):107-11. PubMed ID: 8510081 [TBL] [Abstract][Full Text] [Related]
27. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Lip GY; Edmunds E; Hee FL; Blann AD; Beevers DG Am J Hypertens; 2001 Aug; 14(8 Pt 1):823-8. PubMed ID: 11497201 [TBL] [Abstract][Full Text] [Related]
28. [Molecular markers of endothelial dysfunction in acute ischemic stroke]. Szegedi N; May Z; Ováry C; Skopál J; Nagy Z Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979 [TBL] [Abstract][Full Text] [Related]
29. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435 [TBL] [Abstract][Full Text] [Related]
30. [Endothelial dysfunction in a family with familial combined hyperlipidemia]. Karásek D; Vaverková H; Hutyra M; Halenka M; Novotnyý D; Budíková M; Slavík L Vnitr Lek; 2003 Aug; 49(8):623-9. PubMed ID: 14518086 [TBL] [Abstract][Full Text] [Related]
31. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Glowinska B; Urban M; Peczynska J; Florys B Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051 [TBL] [Abstract][Full Text] [Related]
32. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Boulbou MS; Koukoulis GN; Makri ED; Petinaki EA; Gourgoulianis KI; Germenis AE Int J Cardiol; 2005 Jan; 98(1):39-44. PubMed ID: 15676164 [TBL] [Abstract][Full Text] [Related]
34. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Lip PL; Blann AD; Jones AF; Lip GY Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948 [TBL] [Abstract][Full Text] [Related]
35. von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair. Goldsmith IR; Blann AD; Patel RL; Lip GY Am J Cardiol; 2000 May; 85(10):1218-22. PubMed ID: 10802004 [TBL] [Abstract][Full Text] [Related]
36. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Steiner M; Reinhardt KM; Krammer B; Ernst B; Blann AD Thromb Haemost; 1994 Dec; 72(6):979-84. PubMed ID: 7537916 [TBL] [Abstract][Full Text] [Related]
37. A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation. Fu R; Wu S; Wu P; Qiu J Europace; 2011 Jan; 13(1):31-6. PubMed ID: 20852292 [TBL] [Abstract][Full Text] [Related]
38. von Willebrand factor and soluble E-selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis. Blann AD; Waite MA Coron Artery Dis; 1996 Feb; 7(2):143-7. PubMed ID: 8813446 [TBL] [Abstract][Full Text] [Related]
39. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937 [TBL] [Abstract][Full Text] [Related]
40. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]